ARTICLE | Company News
Alteon deal
June 12, 1995 7:00 AM UTC
ALTN licensed patents covering additional uses of ALTN's lead compound, pimagedine (aminoguanidine), from Washington University (St. Louis) The patents address the ability of pimagedine to inhibit the synthesis of nitric oxide. They encompass potential dermatological applications for the compound as well as possible use in neurovascular and autoimmune diseases. ...